• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯德哥尔摩 III 期试验中直肠癌术前放疗方案的中期分析。

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

出版信息

Br J Surg. 2010 Apr;97(4):580-7. doi: 10.1002/bjs.6914.

DOI:10.1002/bjs.6914
PMID:20155787
Abstract

BACKGROUND

To address issues regarding the fractionation of radiotherapy (RT) and timing of surgery for rectal cancer, a multicentre trial has randomized patients to preoperative short-course RT with two different intervals to surgery, or long-course RT with delayed surgery. The present interim analysis assessed feasibility, compliance and complications after RT and surgery.

METHODS

Some 303 patients were randomized to either short-course RT (5 x 5 Gy) and surgery within 1 week (group 1), short-course RT and surgery after 4-8 weeks (group 2) or long-course RT (25 x 2 Gy) and surgery after 4-8 weeks (group 3).

RESULTS

Demographic data were similar between groups and there were few protocol violations (5.0-6 per cent). Eight patients (2.6 per cent) developed radiation-induced acute toxicity. There were no significant differences in postoperative complications between groups (46.6, 40.0 and 32 per cent in groups 1, 2 and 3 respectively; P = 0.164). Patients receiving short-course RT with surgery 11-17 days after the start of RT had the highest complication rate (24 of 37).

CONCLUSION

Compliance was acceptable and severe acute toxicity was low, irrespective of fractionation. Short-course RT with immediate surgery had a tendency towards more postoperative complications, but only if surgery was delayed beyond 10 days after the start of RT.

REGISTRATION NUMBER

NCT00904813 (http://www.clinicaltrials.gov).

摘要

背景

为了解决直肠癌放疗分割和手术时机的问题,一项多中心试验将患者随机分为术前短程放疗,两种不同间隔时间进行手术,或长程放疗,延迟手术。本中期分析评估了放疗和手术后的可行性、依从性和并发症。

方法

303 例患者被随机分为短程放疗(5 x 5 Gy),术后 1 周内手术(组 1),短程放疗,术后 4-8 周手术(组 2)或长程放疗(25 x 2 Gy),术后 4-8 周手术(组 3)。

结果

各组间的人口统计学数据相似,且方案违规较少(5.0-6%)。8 例(2.6%)发生放射性急性毒性。各组之间的术后并发症无显著差异(组 1、2 和 3 的分别为 46.6%、40.0%和 32.0%;P = 0.164)。接受短程放疗,放疗开始后 11-17 天手术的患者并发症发生率最高(37 例中有 24 例)。

结论

无论分割如何,依从性可接受,严重急性毒性较低。短程放疗后立即手术有增加术后并发症的趋势,但只有在放疗开始后 10 天以上延迟手术时才会出现。

登记号

NCT00904813(http://www.clinicaltrials.gov)。

相似文献

1
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.斯德哥尔摩 III 期试验中直肠癌术前放疗方案的中期分析。
Br J Surg. 2010 Apr;97(4):580-7. doi: 10.1002/bjs.6914.
2
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial.术前放疗对直肠癌患者术后白细胞计数的影响:斯德哥尔摩 III 期临床试验结果
Br J Surg. 2013 Jun;100(7):969-75. doi: 10.1002/bjs.9117. Epub 2013 Apr 2.
3
Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer.术前短程放疗加延期手术治疗原发性直肠癌。
Br J Surg. 2012 Apr;99(4):577-83. doi: 10.1002/bjs.7796. Epub 2012 Jan 12.
4
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.术前放疗的最佳分割和直肠癌手术时机(斯德哥尔摩 III):一项多中心、随机、非盲、III 期、非劣效性试验。
Lancet Oncol. 2017 Mar;18(3):336-346. doi: 10.1016/S1470-2045(17)30086-4. Epub 2017 Feb 10.
5
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.一项比较术前短程放疗与术前常规分割放化疗治疗直肠癌的随机试验的长期结果
Br J Surg. 2006 Oct;93(10):1215-23. doi: 10.1002/bjs.5506.
6
Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.直肠癌术前放疗:三种不同剂量方案的治疗结果
J BUON. 2006 Apr-Jun;11(2):161-6.
7
Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.可切除直肠癌新辅助高剂量率腔内近距离放疗或短程外照射放疗的近期结果。
Colorectal Dis. 2013 Jun;15(6):662-6. doi: 10.1111/codi.12193.
8
Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer.局部进展期直肠癌术前放化疗的毒性和并发症。
Br J Surg. 2011 Mar;98(3):418-26. doi: 10.1002/bjs.7315. Epub 2010 Nov 17.
9
Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.直肠癌辅助放疗:预后预测因素
Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):41-50. doi: 10.1016/0360-3016(94)00493-5.
10
Short versus conventional preoperative radiotherapy of rectal cancer: indications.直肠癌术前短程放疗与传统放疗:适应证
J BUON. 2007 Apr-Jun;12(2):227-32.

引用本文的文献

1
Necessity of neoadjuvant chemoradiation therapy in extremely low rectal cancer initially requiring abdominoperineal resection retrospective study in Korea.韩国极低位直肠癌患者新辅助放化疗的必要性:最初需要腹会阴联合切除术的回顾性研究
Korean J Clin Oncol. 2025 Aug;21(2):98-104. doi: 10.14216/kjco.24316. Epub 2025 Aug 31.
2
Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Current Status and Future Directions.局部晚期直肠癌的新辅助治疗:现状与未来方向
Cancers (Basel). 2025 Jul 31;17(15):2540. doi: 10.3390/cancers17152540.
3
The Benefits of Adjuvant Chemotherapy for ypT3-4N0M0 Rectal Cancer Following Neoadjuvant Chemoradiation and Surgery.
新辅助放化疗及手术后辅助化疗对ypT3-4N0M0期直肠癌的益处
Clin Med Insights Oncol. 2025 Jul 28;19:11795549251359151. doi: 10.1177/11795549251359151. eCollection 2025.
4
Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer-A Systematic Review.局部晚期直肠癌患者当前管理中的争议与展望——一项系统综述
Life (Basel). 2025 Jun 25;15(7):1011. doi: 10.3390/life15071011.
5
How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?我们如何提高局部晚期直肠癌对术前放化疗的肿瘤反应?
Ewha Med J. 2023 Dec;46(Suppl 1):e25. doi: 10.12771/emj.2023.e25. Epub 2023 Dec 31.
6
Automated VMAT planning for short-course radiotherapy in locally advanced rectal cancer.局部晚期直肠癌短程放疗的自动容积调强放疗计划
PLoS One. 2025 Jun 9;20(6):e0325567. doi: 10.1371/journal.pone.0325567. eCollection 2025.
7
Risk Factors for Anastomotic Leak in Patients Undergoing Surgery for Rectal Cancer Resection: A Retrospective Analysis.直肠癌切除手术患者吻合口漏的危险因素:一项回顾性分析
Cureus. 2025 Feb 25;17(2):e79647. doi: 10.7759/cureus.79647. eCollection 2025 Feb.
8
Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US).采用短程放疗和四个周期CAPOX方案对具有高危复发标准的局部晚期直肠癌进行全新辅助治疗:一项瑞典全国队列研究(LARCT-US)
EClinicalMedicine. 2024 Aug 5;75:102771. doi: 10.1016/j.eclinm.2024.102771. eCollection 2024 Sep.
9
The impact of transanal drainage tube on the incidence of anastomotic leakage and small bowel obstruction in radical surgery (Dixon) for rectal cancer: a retrospective cohort study.经肛门引流管对直肠癌根治术(迪克森术)中吻合口漏和小肠梗阻发生率的影响:一项回顾性队列研究
J Gastrointest Oncol. 2024 Aug 31;15(4):1508-1518. doi: 10.21037/jgo-24-537. Epub 2024 Aug 28.
10
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer.推进局部晚期直肠癌治疗中的个性化医疗
J Clin Med. 2024 Apr 26;13(9):2562. doi: 10.3390/jcm13092562.